
|Articles|May 1, 2008
- Pharmaceutical Executive-05-01-2008
- Volume 0
- Issue 0
Pharm Exec 50: The Winners’ Circle
Your guide to the world's top 50 pharma companies. The giants may be struggling, but even in a tough year, the industry's most successful companies know how to hit the bullseye.
Advertisement
Articles in this issue
over 17 years ago
How Not to Handle Rebatesover 17 years ago
Want to Be in a Health Plan? Think Like Oneover 17 years ago
Special Report: Platform Drugs—Marketing Your Opportunitiesover 17 years ago
Q&A with Barbara Yanniover 17 years ago
Ready, Aim, Sellover 17 years ago
Staying in the Gameover 17 years ago
For the People, By the Peopleover 17 years ago
Under Pressureover 17 years ago
Korea's Dream Marketover 17 years ago
Special Report: Platform Drugs—Opportunities in the Market...Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Targeting CCR5 Receptors
2
Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML
3
DEI Changes in Pharma: A Look Back at 2025 & Predictions for 2026
4
Pharmaceutical Executive Daily: WeightWatchers Planning to Offer Wegovy Following Approval
5





